Walasinee Sakcamduang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Walasinee Sakcamduang has a total of 107 co-authors. Here are the top co-authors by number of shared publications:
- Mookmanee Taechikantaphat
Department of Clinical Sciences and Public Health, Faculty of Veterinary Science, Mahidol University, Nakhon Pathom 73170, Thailand
5 shared publications Boonrat Chantong
Affiliation Department of Pre-clinical and Applied Animal Science, Faculty of Veterinary Science, Mahidol University, Salaya, Phutthamonthon, Nakhon Pathom, Thailand
4 shared publicationsAnuwat Wiratsudakul
Affiliations Department of Clinical Sciences and Public Health, Faculty of Veterinary Science, Mahidol University, Salaya, Phutthamonthon, Nakhon Pathom, Thailand, The Monitoring and Surveillance Center for Zoonotic Diseases in Wildlife and Exotic Animals (MoZWE), Faculty of Veterinary Science, Mahidol University, Salaya, Phutthamonthon, Nakhon Pathom, Thailand
3 shared publications- Sarin Suwanpakdee
Faculty of Veterinary Science, Mahidol University, Thailand
3 shared publications - Anuwat Wiratsudakul
Department of Clinical Sciences and Public Health, and the Monitoring and Surveillance Center for Zoonotic Diseases in Wildlife and Exotic Animals, Faculty of Veterinary Science, Mahidol University, Nakhon Pathom, Thailand
2 shared publications - Boonrat Chantong
Department of Pre‐Clinic and Applied Animal Science, Faculty of Veterinary Science Mahidol University Nakhon Pathom Thailand
2 shared publications
Latest Publications
- Open Access
- 14 August 2026
- Published by Wiley in Veterinary Medicine and Science
- Vol. 12 (5) , e71159
Adjunctive Therapy With a Perna canaliculus and Euphausia superba Extract (EAB‐277 TM ) for Clinical Signs of Tracheal Collapse in Dogs: A Prospective, Randomized and Placebo‐Controlled Exploratory Trial
Background: Tracheal collapse is a common canine respiratory disease characterized by dorsoventral cartilage flattening, airway lumen narrowing and subsequent mucosal inflammation. Objectives: To investigate the efficacy of EAB‐277, a marine lipid extract combining Perna canaliculus (30 mg) and Euphausia superba (20 mg) as an adjunctive therapy in the management of tracheal collapse in dogs. Methods: Forty‐one dogs with confirmed tracheal collapse were randomly assigned to receive standard conventional medications plus either EAB‐277 ( n = 21) or a placebo ( n = 20). The EAB‐277 treatment protocol included a loading dose for the initial 14 days. Clinical signs and quality of life were assessed together with fluoroscopy, radiography, haematology and serum biochemistry on Days 0, 14, 28 and 56. Results: Dogs receiving EAB‐277 showed a significant improvement in exercise tolerance by Day 14. Concurrently, fluoroscopic analysis demonstrated significant reductions in the percentage change in tracheal luminal diameter across the cervical, thoracic inlet and intrathoracic regions by Day 14. Both groups showed significant improvements in cough scores throughout the study, with no statistical difference between the groups. Conclusions: Although conventional medical therapy effectively manages the clinical signs of tracheal collapse, particularly cough, this study demonstrates that EAB‐277 provides additional benefits by significantly improving exercise tolerance and reducing dynamic tracheal collapse at the cervical, thoracic inlet and intra‐thoracic regions, which might have the potential to enhance airway health.
- 14 August 2026
- Published by Wiley in Veterinary Medicine and Science
- Vol. 12 (5) , e71159
Open AccessAdjunctive Therapy With a Perna canaliculus and Euphausia superba Extract (EAB‐277 TM ) for Clinical Signs of Tracheal Collapse in Dogs: A Prospective, Randomized and Placebo‐Controlled Exploratory Trial
Background: Tracheal collapse is a common canine respiratory disease characterized by dorsoventral cartilage flattening, airway lumen narrowing and subsequent mucosal inflammation. Objectives: To investigate the efficacy of EAB‐277, a marine lipid extract combining Perna canaliculus (30 mg) and Euphausia superba (20 mg) as an adjunctive therapy in the management of tracheal collapse in dogs. Methods: Forty‐one dogs with confirmed tracheal collapse were randomly assigned to receive standard conventional medications plus either EAB‐277 ( n = 21) or a placebo ( n = 20). The EAB‐277 treatment protocol included a loading dose for the initial 14 days. Clinical signs and quality of life were assessed together with fluoroscopy, radiography, haematology and serum biochemistry on Days 0, 14, 28 and 56. Results: Dogs receiving EAB‐277 showed a significant improvement in exercise tolerance by Day 14. Concurrently, fluoroscopic analysis demonstrated significant reductions in the percentage change in tracheal luminal diameter across the cervical, thoracic inlet and intrathoracic regions by Day 14. Both groups showed significant improvements in cough scores throughout the study, with no statistical difference between the groups. Conclusions: Although conventional medical therapy effectively manages the clinical signs of tracheal collapse, particularly cough, this study demonstrates that EAB‐277 provides additional benefits by significantly improving exercise tolerance and reducing dynamic tracheal collapse at the cervical, thoracic inlet and intra‐thoracic regions, which might have the potential to enhance airway health.
- Open Access
- 15 July 2026
- Published by Elsevier in SSRN Electronic Journal
Prevalence, clinical characteristics, and diagnostic agreement of leptospirosis in azotemic dogs in Bangkok, Thailand
Leptospirosis is a clinically significant yet underrecognized cause of azotemia among dogs in endemic regions. This study evaluated the prevalence, diagnostic particularities, and clinicopathological features of leptospirosis in 100 azotemic dogs (serum creatinine > 1.8 mg/dL) presented to referral hospitals across the Bangkok Metropolitan Region between July 2024 and July 2025. All dogs were evaluated using polymerase chain reaction (PCR) assays on whole blood and urine samples, microagglutination testing (MAT), and a point-of-care (POC) antibody assay. Leptospirosis was identified in 24% of the dogs, among which 10% were classified as confirmed cases and 14% were classified as supportive or suspected cases. The predominant PCR-detected species were Leptospira interrogans, Leptospira licerasiae-related group, and Leptospira yasudae, whereas Shermani was the most common MAT serovar. PCR demonstrated the highest diagnostic sensitivity (76%), substantially outperforming MAT and POC testing. Dogs with leptospirosis also had significantly higher serum creatinine concentrations and urine protein-to-creatinine ratios than dogs without leptospirosis. These findings establish leptospirosis as a common differential diagnosis among azotemic dogs in Thailand and emphasize the need for a multimodal diagnostic approach to reduce underdiagnosis.
- 15 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessPrevalence, clinical characteristics, and diagnostic agreement of leptospirosis in azotemic dogs in Bangkok, Thailand
Leptospirosis is a clinically significant yet underrecognized cause of azotemia among dogs in endemic regions. This study evaluated the prevalence, diagnostic particularities, and clinicopathological features of leptospirosis in 100 azotemic dogs (serum creatinine > 1.8 mg/dL) presented to referral hospitals across the Bangkok Metropolitan Region between July 2024 and July 2025. All dogs were evaluated using polymerase chain reaction (PCR) assays on whole blood and urine samples, microagglutination testing (MAT), and a point-of-care (POC) antibody assay. Leptospirosis was identified in 24% of the dogs, among which 10% were classified as confirmed cases and 14% were classified as supportive or suspected cases. The predominant PCR-detected species were Leptospira interrogans, Leptospira licerasiae-related group, and Leptospira yasudae, whereas Shermani was the most common MAT serovar. PCR demonstrated the highest diagnostic sensitivity (76%), substantially outperforming MAT and POC testing. Dogs with leptospirosis also had significantly higher serum creatinine concentrations and urine protein-to-creatinine ratios than dogs without leptospirosis. These findings establish leptospirosis as a common differential diagnosis among azotemic dogs in Thailand and emphasize the need for a multimodal diagnostic approach to reduce underdiagnosis.
- Open Access
- 13 July 2026
- Published by SAGE Publications in Veterinary Pathology
- Vol. 63 (6) , 1025-1037
Clinicopathological characteristics and clinical outcomes of multiple histological subtypes in feline mammary carcinomas
Feline mammary carcinomas (FMCs) are heterogeneous neoplasms often comprising multiple histological patterns within a single case. The current practice of focusing on a prominent subtype hinders prognostic accuracy and potentially produces suboptimal therapeutic decisions. This retrospective study proposed criteria for grouping these mixed patterns and evaluated their prognostic significance in FMCs. The criteria were based on the tubular carcinoma composition and adopted from those of human breast cancer. Eighty-seven cats with FMCs were divided into groups according to tubular carcinoma composition: pure tubular carcinoma (PTC, n = 34), tubular carcinoma mixed with other subtypes (TMC, n = 16), and nontubular carcinoma (NTC, n = 37). Prognostic factors and overall survival (OS) were compared among the groups. The PTC and TMC groups were significantly associated with early-stage FMCs ( P = .03) and low argyrophilic nucleolar organizer region values ( P = .02). Conversely, NTCs had the poorest prognosis ( P = .03) and were associated with incomplete surgical margins ( P = .004), advanced clinical stage ( P < .001), and high histological grade ( P < .001) on multivariable analysis. Median OS for the PTC, TMC, and NTC groups was 221, 242, and 147 days, respectively. Considering individual histological subtypes, cats with adenosquamous carcinoma had a shorter OS (60 days) than those with comedocarcinoma (147 days) and tubular carcinoma (240 days, P < .001). These criteria were associated with FMC outcome in this cohort, providing a potentially useful framework for prognosis. However, further validation through prospective studies is needed to fully establish their clinical utility.
- 13 July 2026
- Published by SAGE Publications in Veterinary Pathology
- Vol. 63 (6) , 1025-1037
Open AccessClinicopathological characteristics and clinical outcomes of multiple histological subtypes in feline mammary carcinomas
Feline mammary carcinomas (FMCs) are heterogeneous neoplasms often comprising multiple histological patterns within a single case. The current practice of focusing on a prominent subtype hinders prognostic accuracy and potentially produces suboptimal therapeutic decisions. This retrospective study proposed criteria for grouping these mixed patterns and evaluated their prognostic significance in FMCs. The criteria were based on the tubular carcinoma composition and adopted from those of human breast cancer. Eighty-seven cats with FMCs were divided into groups according to tubular carcinoma composition: pure tubular carcinoma (PTC, n = 34), tubular carcinoma mixed with other subtypes (TMC, n = 16), and nontubular carcinoma (NTC, n = 37). Prognostic factors and overall survival (OS) were compared among the groups. The PTC and TMC groups were significantly associated with early-stage FMCs ( P = .03) and low argyrophilic nucleolar organizer region values ( P = .02). Conversely, NTCs had the poorest prognosis ( P = .03) and were associated with incomplete surgical margins ( P = .004), advanced clinical stage ( P < .001), and high histological grade ( P < .001) on multivariable analysis. Median OS for the PTC, TMC, and NTC groups was 221, 242, and 147 days, respectively. Considering individual histological subtypes, cats with adenosquamous carcinoma had a shorter OS (60 days) than those with comedocarcinoma (147 days) and tubular carcinoma (240 days, P < .001). These criteria were associated with FMC outcome in this cohort, providing a potentially useful framework for prognosis. However, further validation through prospective studies is needed to fully establish their clinical utility.
- Open Access
- 16 April 2026
- Published by Elsevier in Veterinary and Animal Science
- Vol. 32, 100661
Comparative efficacy of once-daily versus twice-daily doxycycline regimens in dogs naturally infected with Ehrlichia canis: A randomized clinical trial
- 16 April 2026
- Published by Elsevier in Veterinary and Animal Science
- Vol. 32, 100661
Open AccessComparative efficacy of once-daily versus twice-daily doxycycline regimens in dogs naturally infected with Ehrlichia canis: A randomized clinical trial
- Open Access
- 19 December 2025
- Published by Wiley in Veterinary and Comparative Oncology
- Vol. 24 (1) , 128-139
Tissue Proteomics of Feline Mammary Carcinoma: Differences in Protein Profiles Among Histological Grades Using Liquid Chromatography–Tandem Mass Spectrometry
Mammary carcinomas are aggressive neoplasms and a significant cause of mortality in female cats. Despite surgical removal, feline mammary carcinoma (FMC) often recurs or metastasizes. Specific tumour biomarkers are necessary for early detection, prognosis and therapy selection. This study aims to identify candidate biomarkers for FMC by comparing tissue proteomic profiles among grades of 31 FMC cats and six normal mammary tissues (control) using liquid chromatography coupled with tandem mass spectrometry (LC–MS/MS). Candidate proteins identified by LC–MS/MS were validated by Western blotting and LC–MS/MS. Prognostic values of candidate proteins were evaluated using immunohistochemistry and survival analysis. Protein‐chemotherapy drug interaction networks were also evaluated. Among the 268 differential proteins observed, dermatopontin (DPT) expression was significantly downregulated, while sorting nexin 5 (SNX5) expression was elevated in cancerous tissues compared to controls ( p < 0.05). Immunohistochemistry results revealed a significant association of DPT and SNX5 with stages (DPT, p < 0.0001; SNX5, p = 0.046) and grades of FMC (DPT, p < 0.0001; SNX5, p = 0.04). Low DPT expression was associated with poor overall survival ( p = 0.02), along with Stage 4 FMC ( p = 0.0001), high mitotic count ( p = 0.003) and the presence of lymphovascular invasion ( p = 0.003). Moreover, protein‐chemotherapy drug interaction showed a relationship of DPT with doxorubicin, lapatinib and neratinib. This study identified DPT and SNX5 as potential diagnostic and therapeutic targets for FMC, with DPT emerging as a promising prognostic biomarker.
- 19 December 2025
- Published by Wiley in Veterinary and Comparative Oncology
- Vol. 24 (1) , 128-139
Open AccessTissue Proteomics of Feline Mammary Carcinoma: Differences in Protein Profiles Among Histological Grades Using Liquid Chromatography–Tandem Mass Spectrometry
Mammary carcinomas are aggressive neoplasms and a significant cause of mortality in female cats. Despite surgical removal, feline mammary carcinoma (FMC) often recurs or metastasizes. Specific tumour biomarkers are necessary for early detection, prognosis and therapy selection. This study aims to identify candidate biomarkers for FMC by comparing tissue proteomic profiles among grades of 31 FMC cats and six normal mammary tissues (control) using liquid chromatography coupled with tandem mass spectrometry (LC–MS/MS). Candidate proteins identified by LC–MS/MS were validated by Western blotting and LC–MS/MS. Prognostic values of candidate proteins were evaluated using immunohistochemistry and survival analysis. Protein‐chemotherapy drug interaction networks were also evaluated. Among the 268 differential proteins observed, dermatopontin (DPT) expression was significantly downregulated, while sorting nexin 5 (SNX5) expression was elevated in cancerous tissues compared to controls ( p < 0.05). Immunohistochemistry results revealed a significant association of DPT and SNX5 with stages (DPT, p < 0.0001; SNX5, p = 0.046) and grades of FMC (DPT, p < 0.0001; SNX5, p = 0.04). Low DPT expression was associated with poor overall survival ( p = 0.02), along with Stage 4 FMC ( p = 0.0001), high mitotic count ( p = 0.003) and the presence of lymphovascular invasion ( p = 0.003). Moreover, protein‐chemotherapy drug interaction showed a relationship of DPT with doxorubicin, lapatinib and neratinib. This study identified DPT and SNX5 as potential diagnostic and therapeutic targets for FMC, with DPT emerging as a promising prognostic biomarker.
- Open Access
- 8 October 2025
- Published by Veterinary World in Veterinary World
- Vol. 18 (10) , 2969-2980
Survival outcomes and prognostic indicators in canine pancreatitis: A retrospective cohort study of acute kidney injury and concurrent diseases
Background and Aim: Canine pancreatitis is often complicated by acute kidney injury (AKI) and systemic comorbidities, both of which may worsen clinical outcomes. This study aimed to evaluate survival rates in dogs with pancreatitis, stratified by the presence of AKI and other concurrent diseases, and to identify prognostic indicators for mortality. Materials and Methods: A retrospective cohort study was conducted at Prasu Arthorn Veterinary Teaching Hospital, Mahidol University, Thailand, from February 2021 to February 2023. Medical records of 146 dogs diagnosed with pancreatitis (serum canine pancreatic lipase ≥400 μg/L and clinical signs) were reviewed. Dogs were categorized into four groups: Pancreatitis alone (n = 24), pancreatitis with AKI (n = 28), pancreatitis with concurrent diseases (n = 57), and pancreatitis with both AKI and concurrent diseases (n = 34). Survival was analyzed using Kaplan–Meier curves and log-rank tests, while prognostic factors were assessed using Cox proportional hazards regression. Results: The overall mortality rate was 39.72% (58/146), with the highest mortality in dogs with AKI (Groups 2 and 4). Median survival was 4 days (95% confidence interval [CI]: 0.0–11.7) in Group 2 and 7 days (95% CI: 2.7–11.2) in Group 4, while median survival was not reached in Groups 1 and 3 due to high survival. Hematocrit (HCT) and blood urea nitrogen-to-creatinine ratio (BCR) were identified as independent predictors of mortality. Lower HCT (Hazard ratio [HR] = 0.967, 95% CI: 0.941–0.994, p = 0.019) and higher BCR (HR = 1.024, 95% CI: 1.007–1.041, p = 0.006) were significantly associated with increased risk of death. Conclusion: AKI is a major negative prognostic factor in canine pancreatitis, markedly reducing survival irrespective of concurrent systemic diseases. Readily available markers, such as HCT and BCR, provide practical tools for early triage and prognostic stratification. Incorporating these parameters into clinical decision-making may enhance outcomes by guiding intensive monitoring and targeted interventions. Keywords: acute kidney injury, blood urea nitrogen-to-creatinine ratio, canine pancreatitis, concurrent diseases, hematocrit, prognostic markers, survival analysis.
- 8 October 2025
- Published by Veterinary World in Veterinary World
- Vol. 18 (10) , 2969-2980
Open AccessSurvival outcomes and prognostic indicators in canine pancreatitis: A retrospective cohort study of acute kidney injury and concurrent diseases
Background and Aim: Canine pancreatitis is often complicated by acute kidney injury (AKI) and systemic comorbidities, both of which may worsen clinical outcomes. This study aimed to evaluate survival rates in dogs with pancreatitis, stratified by the presence of AKI and other concurrent diseases, and to identify prognostic indicators for mortality. Materials and Methods: A retrospective cohort study was conducted at Prasu Arthorn Veterinary Teaching Hospital, Mahidol University, Thailand, from February 2021 to February 2023. Medical records of 146 dogs diagnosed with pancreatitis (serum canine pancreatic lipase ≥400 μg/L and clinical signs) were reviewed. Dogs were categorized into four groups: Pancreatitis alone (n = 24), pancreatitis with AKI (n = 28), pancreatitis with concurrent diseases (n = 57), and pancreatitis with both AKI and concurrent diseases (n = 34). Survival was analyzed using Kaplan–Meier curves and log-rank tests, while prognostic factors were assessed using Cox proportional hazards regression. Results: The overall mortality rate was 39.72% (58/146), with the highest mortality in dogs with AKI (Groups 2 and 4). Median survival was 4 days (95% confidence interval [CI]: 0.0–11.7) in Group 2 and 7 days (95% CI: 2.7–11.2) in Group 4, while median survival was not reached in Groups 1 and 3 due to high survival. Hematocrit (HCT) and blood urea nitrogen-to-creatinine ratio (BCR) were identified as independent predictors of mortality. Lower HCT (Hazard ratio [HR] = 0.967, 95% CI: 0.941–0.994, p = 0.019) and higher BCR (HR = 1.024, 95% CI: 1.007–1.041, p = 0.006) were significantly associated with increased risk of death. Conclusion: AKI is a major negative prognostic factor in canine pancreatitis, markedly reducing survival irrespective of concurrent systemic diseases. Readily available markers, such as HCT and BCR, provide practical tools for early triage and prognostic stratification. Incorporating these parameters into clinical decision-making may enhance outcomes by guiding intensive monitoring and targeted interventions. Keywords: acute kidney injury, blood urea nitrogen-to-creatinine ratio, canine pancreatitis, concurrent diseases, hematocrit, prognostic markers, survival analysis.
- Open Access
- 29 September 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (9) , e0333526
Clinical improvement in canine pulmonary hypertension with Perna canaliculus oil (PCSO-524) add-on therapy: Effects on exercise tolerance and cough
Pulmonary hypertension (PH) in dogs, characterized by abnormally high blood pressure in the pulmonary arteries, presents a management challenge, and adjunctive therapies for the standard treatment of sildenafil are needed. This study aimed to determine whether the nutraceutical Perna canaliculus oil (PCSO-524), a marine lipid extract with anti-inflammatory properties, provides additional clinical benefits to dogs with PH. In a prospective, randomized, placebo-controlled trial, seventeen client-owned dogs diagnosed with PH were assigned to receive either PCSO-524 or a placebo as an add-on to their sildenafil-based therapy for 70 days. Key outcomes were evaluated using owner-assessed clinical scores for exercise tolerance and coughing, alongside echocardiographic measurements. The PCSO-524 group demonstrated a statistically significant improvement in exercise tolerance scores by day 70 (P = 0.009). This group also showed a greater reduction in coughing scores compared to the placebo group between day 35 and day 70 (P = 0.03). While the tricuspid regurgitation pressure gradient (TRPG), an estimate of pulmonary pressure, decreased significantly over time in all dogs (P = 0.001), no significant difference was found between the groups for this specific measure. These results indicate that PCSO-524 can serve as a beneficial adjunctive therapy for improving important clinical signs, such as exercise tolerance and coughing, in dogs with PH. This suggests it may be a valuable addition to standard management for enhancing quality of life.
- 29 September 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (9) , e0333526
Open AccessClinical improvement in canine pulmonary hypertension with Perna canaliculus oil (PCSO-524) add-on therapy: Effects on exercise tolerance and cough
Pulmonary hypertension (PH) in dogs, characterized by abnormally high blood pressure in the pulmonary arteries, presents a management challenge, and adjunctive therapies for the standard treatment of sildenafil are needed. This study aimed to determine whether the nutraceutical Perna canaliculus oil (PCSO-524), a marine lipid extract with anti-inflammatory properties, provides additional clinical benefits to dogs with PH. In a prospective, randomized, placebo-controlled trial, seventeen client-owned dogs diagnosed with PH were assigned to receive either PCSO-524 or a placebo as an add-on to their sildenafil-based therapy for 70 days. Key outcomes were evaluated using owner-assessed clinical scores for exercise tolerance and coughing, alongside echocardiographic measurements. The PCSO-524 group demonstrated a statistically significant improvement in exercise tolerance scores by day 70 (P = 0.009). This group also showed a greater reduction in coughing scores compared to the placebo group between day 35 and day 70 (P = 0.03). While the tricuspid regurgitation pressure gradient (TRPG), an estimate of pulmonary pressure, decreased significantly over time in all dogs (P = 0.001), no significant difference was found between the groups for this specific measure. These results indicate that PCSO-524 can serve as a beneficial adjunctive therapy for improving important clinical signs, such as exercise tolerance and coughing, in dogs with PH. This suggests it may be a valuable addition to standard management for enhancing quality of life.
- Open Access
- 22 August 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (8) , e0330750
Antibiotic use in companion animals in veterinary teaching hospitals in Thailand
The high volume of antibiotics used for companion animals, off-label use of human-registered antibiotics for veterinary purposes, and close human-animal interactions raises policy concerns related to antimicrobial resistance in companion animals. This study aimed to assess the volume and type of antibiotic usage in companion animals at veterinary teaching hospitals in Thailand. In 2018, we obtained a dataset of visits that occurred between 2015 and 2017 from eight selected veterinary teaching hospitals with a high caseload of companion animals. In total, we included 938,522 dogs and 242,342 cats in our study. Total antibiotic consumption was estimated, and antibiotic usage was standardized by calculating the amount of antibiotic consumed by weight per year (mg/kg/year). The top five antibiotics used include amoxicillin–clavulanic acid, enrofloxacin, cephalexin, doxycycline, and metronidazole, all of which are commonly used to treat bacterial and parasitic infections. Critically important antimicrobials for human medicine, such as amoxicillin–clavulanic acid and enrofloxacin, were among the most used. From 2015 to 2017, total antibiotic usage (kg) markedly decreased (i.e., by 57.0%), with a particularly notable reduction of 78.2% observed for amoxicillin–clavulanic acid. Moreover, veterinarians’ overall prescriptions of antibiotics registered for human use decreased by 16% over the same period. However, there was a notable increase in the use of injectable antibiotics registered for human use relative to oral forms. Furthermore, we observed a relatively high usage of third-generation cephalosporins, which may contribute to the emergence of antimicrobial resistance in companion animals. This study emphasizes the need to educate veterinarians and veterinary students on the rational use of antibiotics and highlights the importance of regular monitoring and surveillance of antibiotic use in companion animals.
- 22 August 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (8) , e0330750
Open AccessAntibiotic use in companion animals in veterinary teaching hospitals in Thailand
The high volume of antibiotics used for companion animals, off-label use of human-registered antibiotics for veterinary purposes, and close human-animal interactions raises policy concerns related to antimicrobial resistance in companion animals. This study aimed to assess the volume and type of antibiotic usage in companion animals at veterinary teaching hospitals in Thailand. In 2018, we obtained a dataset of visits that occurred between 2015 and 2017 from eight selected veterinary teaching hospitals with a high caseload of companion animals. In total, we included 938,522 dogs and 242,342 cats in our study. Total antibiotic consumption was estimated, and antibiotic usage was standardized by calculating the amount of antibiotic consumed by weight per year (mg/kg/year). The top five antibiotics used include amoxicillin–clavulanic acid, enrofloxacin, cephalexin, doxycycline, and metronidazole, all of which are commonly used to treat bacterial and parasitic infections. Critically important antimicrobials for human medicine, such as amoxicillin–clavulanic acid and enrofloxacin, were among the most used. From 2015 to 2017, total antibiotic usage (kg) markedly decreased (i.e., by 57.0%), with a particularly notable reduction of 78.2% observed for amoxicillin–clavulanic acid. Moreover, veterinarians’ overall prescriptions of antibiotics registered for human use decreased by 16% over the same period. However, there was a notable increase in the use of injectable antibiotics registered for human use relative to oral forms. Furthermore, we observed a relatively high usage of third-generation cephalosporins, which may contribute to the emergence of antimicrobial resistance in companion animals. This study emphasizes the need to educate veterinarians and veterinary students on the rational use of antibiotics and highlights the importance of regular monitoring and surveillance of antibiotic use in companion animals.
- Open Access
- 7 May 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (5) , e0321509
Plasma-based proteomics analysis of molecular pathways in canine diabetes mellitus after astaxanthin supplementation
The hyperglycemic state in diabetes mellitus induces oxidative stress and inflammation, contributing to diabetic tissue damage and associated complications. Astaxanthin, a potent antioxidant carotenoid, has been investigated for its potential to prevent and manage diabetes across various species; however, its effect on client-owned dogs remains poorly studied. This study explored the impact of astaxanthin supplementation on canine diabetes mellitus using a proteomics approach. A total of 18 client-owned dogs were enrolled: 6 dogs with diabetes mellitus and 12 clinically healthy dogs. The diabetic dogs received their standard treatment regimen along with daily oral supplementation of 12 mg of astaxanthin (1.5–2.4 mg/kg) for 90 days. Plasma samples were collected at the beginning and end of the study period for proteomics analysis. After astaxanthin supplementation, significant alterations in the expression of proteins associated with the complement system, coagulation cascade, JAK–STAT signaling, and protein kinase C signaling (all of which contribute to inflammation and oxidative stress) were observed. Astaxanthin exhibited potential for reducing diabetes-associated complications, such as insulin resistance, vascular dysfunction, nephropathy, and cardiac issues, even though it did not affect clinical parameters (hematology, plasma biochemistry, blood glucose, and serum fructosamine). These findings suggest that astaxanthin may be a valuable complementary therapy for managing diabetes-related complications in canines.
- 7 May 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (5) , e0321509
Open AccessPlasma-based proteomics analysis of molecular pathways in canine diabetes mellitus after astaxanthin supplementation
The hyperglycemic state in diabetes mellitus induces oxidative stress and inflammation, contributing to diabetic tissue damage and associated complications. Astaxanthin, a potent antioxidant carotenoid, has been investigated for its potential to prevent and manage diabetes across various species; however, its effect on client-owned dogs remains poorly studied. This study explored the impact of astaxanthin supplementation on canine diabetes mellitus using a proteomics approach. A total of 18 client-owned dogs were enrolled: 6 dogs with diabetes mellitus and 12 clinically healthy dogs. The diabetic dogs received their standard treatment regimen along with daily oral supplementation of 12 mg of astaxanthin (1.5–2.4 mg/kg) for 90 days. Plasma samples were collected at the beginning and end of the study period for proteomics analysis. After astaxanthin supplementation, significant alterations in the expression of proteins associated with the complement system, coagulation cascade, JAK–STAT signaling, and protein kinase C signaling (all of which contribute to inflammation and oxidative stress) were observed. Astaxanthin exhibited potential for reducing diabetes-associated complications, such as insulin resistance, vascular dysfunction, nephropathy, and cardiac issues, even though it did not affect clinical parameters (hematology, plasma biochemistry, blood glucose, and serum fructosamine). These findings suggest that astaxanthin may be a valuable complementary therapy for managing diabetes-related complications in canines.